Skip to main content
West Pharmaceutical Services10-Q: CEO change

CEO Eric M. Green adopts Rule 10b5-1 trading plan for 83,616 shares.

What happened

In March 2026, CEO Eric M. Green established a pre-arranged trading plan to exercise options and sell 83,616 shares in February 2027. While a common practice for executives, such large, planned transactions can signal long-term strategic planning or personal liquidity events that may influence leadership focus.

Source

SEC EDGARApr 23, 2026

Quarterly report (Form 10-Q)

West Pharmaceutical Services 10-Q

Filing excerpt

On March 11, 2026, Eric M. Green, our President and Chief Executive Officer and Chair of the Board of Directors, adopted a Rule 10b5-1 trading arrangement, which is intended to satisfy the affirmative defense of Rule 10b5-1(c) with respect to options that will be expiring on February 21, 2027.

sec.gov/Archives/edgar/data/105770/000010577026000049/wst-20260331.htmRead the full source

Other signals in this filing (9)

Extracted by Autobound

From the Signal API record
Signal
10-Q: CEO change

What this signalsA new leader often reviews the tools the team uses.

Fiscal year end
03/31
Filed
Apr 23, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Details

CIK
105770
Accession number
0000105770-26-000049
Filing year
2026
Fiscal year
0
Why it matters
Full vendor review - highest priority
Signal category
Leadership

Extraction

Confidence
High
Relevance
70%
Sentiment
Neutral
Detected
Apr 28, 2026
signal_type
sec-10q
signal_subtype
ceoChange

Use this data

Get every 10-Q signal for West Pharmaceutical Services and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at West Pharmaceutical Services this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/1b5dbc35-a6a0-4556-9ba6-62a4c2a85e1f returns this record as JSON. POST /v1/companies/enrich returns every signal for westpharma.com.

{
  "signal_id": "1b5dbc35-a6a0-4556-9ba6-62a4c2a85e1f",
  "signal_type": "sec-10q",
  "signal_subtype": "ceoChange",
  "detected_at": "2026-04-28T10:05:23.255+00:00",
  "company": {
    "name": "West Pharmaceutical Services",
    "domain": "westpharma.com"
  },
  "data": {
    "detail": "In March 2026, CEO Eric M. Green established a pre-arranged trading plan to exercise options and sell 83,616 shares in February 2027. While a common practice for executives, such large, planned transactions can signal long-term strategic planning or personal liquidity events that may influence leadership focus.",
    "summary": "CEO Eric M. Green adopts Rule 10b5-1 trading plan for 83,616 shares.",
    "excerpts": "On March 11, 2026, Eric M. Green, our President and Chief Executive Officer and Chair of the Board of Directors, adopted a Rule 10b5-1 trading arrangement, which is intended to satisfy the affirmative defense of Rule 10b5-1(c) with respect to options that will be expiring on February 21, 2027.",
    "relevance": 0.7,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/105770/000010577026000049/wst-20260331.htm",
    "filing_date": "2026-04-23",
    "filing_year": 2026,
    "fiscal_year": 0,
    "fiscal_year_end": "03/31",
    "sales_relevance": "Full vendor review - highest priority",
    "signal_category": "leadership"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.